ArticleFrontiers in medicine2026
Redistribution of peripheral blood immune cell subsets and remodeling of intercellular communication in rare Behçet's disease: a single-cell transcriptomics study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Behçet's disease (BD) is a rare chronic systemic vasculitis of unknown etiology. The heterogeneity of peripheral blood immune cells and the dysregulation of intercellular communication in BD remain insufficiently characterized. The present study employs single-cell transcriptomics to comprehensively delineate the peripheral blood immune cell atlas of BD, identify candidate diagnostic biomarkers, and dissect the remodeling patterns of intercellular communication networks. Methods: Single-cell RNA sequencing data of peripheral blood mononuclear cells (PBMCs) from 8 BD patients and 8 healthy controls (HCs) (GSE198616) were analyzed using Seurat v5, clusterProfiler, LASSO regression, and CellChat v1.6. Differential expression analysis at both single-cell and pseudobulk levels, GSEA, and ssGSEA were performed, with external validation carried out using two independent transcriptomic datasets (GSE61399 and GSE205867). Results: Nine major immune cell types were identified, and monocytes were further subdivided into three subsets. BD patients exhibited subset-specific monocyte redistribution at the group level: CD14 Conclusion: This study delineates the peripheral blood immune landscape of BD, revealing subset-specific monocyte redistribution and subtype-specific remodeling of intercellular communication. These findings generate new hypotheses for diagnostic biomarker development and communication-targeted therapeutic strategies in BD, warranting further experimental validation in well-phenotyped cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.